$1.08
3.85% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US31447E1055
Symbol
FEMY

Femasys Inc Stock price

$1.08
-0.12 10.00% 1M
+0.10 10.54% 6M
-0.02 1.82% YTD
-0.18 14.29% 1Y
-0.62 36.47% 3Y
-10.92 91.00% 5Y
-10.92 91.00% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.04 3.85%
ISIN
US31447E1055
Symbol
FEMY
Sector

Key metrics

Market capitalization $29.42m
Enterprise Value $33.27m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 19.57
P/S ratio (TTM) P/S ratio 17.31
P/B ratio (TTM) P/B ratio 14.65
Revenue growth (TTM) Revenue growth 61.97%
Revenue (TTM) Revenue $1.70m
EBIT (operating result TTM) EBIT $-19.78m
Free Cash Flow (TTM) Free Cash Flow $-20.43m
Cash position $3.82m
EPS (TTM) EPS $-0.91
P/E forward negative
P/S forward 4.43
EV/Sales forward 5.01
Short interest 3.80%
Show more

Is Femasys Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Femasys Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Femasys Inc forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Femasys Inc forecast:

Buy
100%

Financial data from Femasys Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1.70 1.70
62% 62%
100%
- Direct Costs 1.44 1.44
12% 12%
85%
0.26 0.26
208% 208%
15%
- Selling and Administrative Expenses 9.76 9.76
54% 54%
574%
- Research and Development Expense 9.41 9.41
26% 26%
554%
-19 -19
35% 35%
-1,113%
- Depreciation and Amortization 0.87 0.87
5% 5%
51%
EBIT (Operating Income) EBIT -20 -20
33% 33%
-1,164%
Net Profit -21 -21
42% 42%
-1,242%

In millions USD.

Don't miss a Thing! We will send you all news about Femasys Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Femasys Inc Stock News

Neutral
GlobeNewsWire
12 days ago
-- Company delivers on mission to transform women's health with innovative solutions, including FemaSeed ® for first-line infertility treatment and FemBloc ® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health wor...
Neutral
GlobeNewsWire
about 2 months ago
-- Company expands commercial product offering with FemBloc ® permanent birth control (delivery system) approval in Europe and signed partnerships for distribution in Spain -- ATLANTA, March 27, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-...
Neutral
GlobeNewsWire
2 months ago
Femasys continues to expand access and market share for its first-line infertility treatment option Femasys continues to expand access and market share for its first-line infertility treatment option
More Femasys Inc News

Company Profile

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. Its products include FemVue Saline-Air Device, which creates and delivers an alternating pattern of saline and air as a continuous stream, and enables physicians to assess their patients fallopian tubes, and FemChec Pressure Management Device, which limits the maximum applied pressure while performing hysterosalpingogram. The firm offers FemCerv, an endocervical curettage device to collect a non-contaminated tissue sample for cervical cancer screening. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.

Head office United States
CEO Kathy Lee-Sepsick
Employees 71
Founded 2004
Website www.femasys.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today